Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| May 5 | MRK | Merck & Co., Inc. | AGRANT◆ | 58,207 | — | — | — | Open the original filing on SEC.gov |
| May 5 | MRK | Merck & Co., Inc. | AGRANT◆ | 19,885 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | MEXER◆ | 4,722 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | FTAX | 2,326 | $110.03 | $255.9K | -2.4% | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | MEXER | 4,722 | $110.03 | $519.6K | +5.1% | Open the original filing on SEC.gov |
| Apr 1 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 3,268 | — | — | +0.3% | Open the original filing on SEC.gov |
| Feb 10 | MRK | Merck & Co., Inc. | SSELL | 10,235 | $117.52 | $1.2M | -10.0% | Open the original filing on SEC.gov |
| Feb 4 | MRK | Merck & Co., Inc. | MEXER◆ | 15,087 | — | — | — | Open the original filing on SEC.gov |
| Feb 4 | MRK | Merck & Co., Inc. | SSELL | 15,087 | $118.77 | $1.8M | -12.9% | Open the original filing on SEC.gov |
| Feb 4 | MRK | Merck & Co., Inc. | MEXER | 15,087 | $56.04 | $845.5K | +14.8% | Open the original filing on SEC.gov |
| Jan 26 | MRK | Merck & Co., Inc. | AGRANT | 20,469 | $107.40 | $2.2M | +25.0% | Open the original filing on SEC.gov |
| Jan 2 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 2,381 | — | — | +0.2% | Open the original filing on SEC.gov |
| Oct 1, 2025 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 1,961 | — | — | +0.2% | Open the original filing on SEC.gov |
| Jul 1, 2025 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 1,949 | — | — | +0.2% | Open the original filing on SEC.gov |
| Jun 18, 2025 | RXRX | Recursion Pharmaceuticals,… | AGRANT◆ | 44,031 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 22,016 | — | — | +1.8% | Open the original filing on SEC.gov |
| Apr 29, 2025 | MRK | Merck & Co., Inc. | AGRANT◆ | 64,481 | — | — | — | Open the original filing on SEC.gov |
| Apr 29, 2025 | MRK | Merck & Co., Inc. | AGRANT◆ | 14,166 | — | — | — | Open the original filing on SEC.gov |